Skip to main content

Kamada Ltd

KMDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001567529

In the last 90 days, Kamada Ltd insiders filed 0 open-market purchases and 2 sales; 51 institutions reported holding it in 13F filings for Q2 2026, worth $36.7M in total; ARK Invest is the only superinvestor holding it.

Q4 2023 vs. Q3 2023

How the institutions holding Kamada Ltd changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of KMDA: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders2529+4
Shares5.75M5.78M+25.5K (+0.4%)
Value$30.8M$36.9M+$6.06M (+19.7%)

New holders (8)

Institutions that held Kamada Ltd at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to KMDA in Q4 2023
InstitutionSharesValue% of portfolio
Calton & Associates, Inc.18,124$110.9K0.04%
Susquehanna International Group, LLP16,369$100.2K0.00%
JPMorgan Chase & Co13,673$83.7K0.00%
Walleye Capital LLC11,743$71.9K0.00%
Ewa, LLC11,851$67.8K0.03%
Simplex Trading, LLC7,005$42.0K0.00%
GWM Advisors LLC2,724$16.7K0.00%
Group One Trading, L.P.800$4.90K0.00%

Sold out (4)

Institutions that held Kamada Ltd at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of KMDA in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Norges Bank33,595$181.1K
Goldman Sachs Group Inc10,873$58.1K
Tower Research Capital LLC (TRC)357$1.91K
BNP Paribas Arbitrage, SA251$1.34K